Enter your details below. We'll calculate your BMI, project your timeline, and recommend the protocol that fits your goals.
All fields are used to personalize your results.
Conservative to optimistic range based on GLP-1 clinical data
Based on clinical trial data, participants on branded semaglutide (Wegovy) in the STEP-1 trial (Wilding et al., NEJM 2021) lost an average of approximately 15% of their body weight over 68 weeks. These results reflect branded semaglutide studied under controlled trial conditions. Individual results vary based on dosage, diet, exercise, and adherence.
Based on your BMI and goals, here is what we recommend.
This calculator is for informational purposes only. Individual results may vary based on metabolism, adherence, diet, exercise, and other health factors.
BMI is one measure of health and does not account for muscle mass, bone density, age distribution of body fat, or other factors that influence overall health.
Consult a healthcare provider before starting any weight loss program. All medications require a prescription from a licensed clinician after a telehealth evaluation.